BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 2452769)

  • 1. A phase II trial of mitomycin, vincristine, bleomycin, and cisplatin (MOBP) as neoadjuvant therapy in high-risk cervical carcinoma.
    Weiner SA; Aristizabal S; Alberts DS; Surwit EA; Deatherage-Deuser K
    Gynecol Oncol; 1988 May; 30(1):1-6. PubMed ID: 2452769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized study of primary bleomycin, vincristine, mitomycin and cisplatin (BOMP) chemotherapy followed by radiotherapy versus radiotherapy alone in stage IIIB and IVA squamous cell carcinoma of the cervix.
    Tabata T; Takeshima N; Nishida H; Hirai Y; Hasumi K
    Anticancer Res; 2003; 23(3C):2885-90. PubMed ID: 12926129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy for advanced and/or recurrent cervical cancer.
    Lahousen M; Pickel H; Tamussino K
    Arch Gynecol; 1987; 240(4):247-52. PubMed ID: 2440389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
    Alberts DS; Kronmal R; Baker LH; Stock-Novack DL; Surwit EA; Boutselis JG; Hannigan EV
    J Clin Oncol; 1987 Nov; 5(11):1791-5. PubMed ID: 2445932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bleomycin, vincristine, mitomycin C, and cis-platinum in gynecologic squamous cell carcinomas: a high incidence of pulmonary toxicity.
    Chambers SK; Flynn SD; Del Prete SA; Chambers JT; Schwartz PE
    Gynecol Oncol; 1989 Mar; 32(3):303-9. PubMed ID: 2465939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
    Lele SB; Piver MS
    Gynecol Oncol; 1989 Apr; 33(1):6-8. PubMed ID: 2467845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin].
    Shimizu Y; Nakayama K; Seimiya Y; Yamakawa Y; Koi S; Yokosuka K; Teshima H; Chen JT; Fujimoto I; Yamauchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):549-56. PubMed ID: 1711555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bleomycin, vincristine, mitomycin-C, and cisplatin in the management of gynecological squamous cell carcinomas.
    Belinson JL; Stewart JA; Richards AL; McClure M
    Gynecol Oncol; 1985 Mar; 20(3):387-93. PubMed ID: 2579010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma.
    Shimizu Y; Akiyama F; Umezawa S; Ishiya T; Utsugi K; Hasumi K
    J Clin Oncol; 1998 May; 16(5):1869-78. PubMed ID: 9586903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short duration neoadjuvant chemotherapy followed by radiotherapy for advanced carcinoma of the cervix: results and prognostic variables.
    Seoud M; Geara FB; Shamseddine A; Salem Z; Khalil A
    Eur J Gynaecol Oncol; 2003; 24(2):163-8. PubMed ID: 12701970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemotherapy with vincristine and cisplatin followed by radical hysterectomy and pelvic lymphadenectomy for FIGO stage IB bulky cervical cancer: a Gynecologic Oncology Group pilot study.
    Eddy GL; Manetta A; Alvarez RD; Williams L; Creasman WT
    Gynecol Oncol; 1995 Jun; 57(3):412-6. PubMed ID: 7774847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vincristine, bleomycin, mitomycin C, cisplatin combination chemotherapy as additive treatment to radiotherapy in poor risk patients with squamous cell carcinoma of the uterine cervix.
    Vermorken JB; vd Burg ME; Subandono AJ; Mangioni C; De Oliveira CF; Zola P; van Oosterom AT; Pecorelli S; van Lindert AC
    Prog Clin Biol Res; 1985; 201():225-37. PubMed ID: 2419917
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy of cancers of the uterine cervix with a combination of bleomycin, mitomycin, cisplatin and etoposide].
    Chauvergne J; Héron JF; Mayer F; Charrot-Chinet P; Toulouse C
    Bull Cancer; 1993 Jan; 80(1):70-9. PubMed ID: 7515729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concurrent chemoradiotherapy versus radiotherapy in advanced cervical carcinoma].
    Zeng SY; Li LY; Shu KY; Pan M; Li HP; Luo B
    Ai Zheng; 2008 Sep; 27(9):942-6. PubMed ID: 18799032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of concurrent radiotherapy and chemotherapy with cis-platinum, vincristine, and bleomycin in bulky, advanced cervical carcinoma: a pilot study.
    Chang HC; Lai CH; Chen MS; Chao AS; Chen LH; Soong YK
    Gynecol Oncol; 1992 Feb; 44(2):182-8. PubMed ID: 1371978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination chemotherapy for patients with advanced carcinoma of the cervix: trial of mitomycin-C, vincristine, bleomycin, and cisplatin.
    Giannone L; Brenner DE; Jones HW; Greco FA; Burnett LS
    Gynecol Oncol; 1987 Feb; 26(2):178-82. PubMed ID: 2433196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intensive sequential chemotherapy with bleomycin, Oncovin, mitomycin C, and methotrexate followed by adriamycin, cisplatin, and cyclosphosphamide in squamous cell cancer of the head and neck.
    Wheeler RH; Baker SR; Liepman MK; Ensminger WD
    Med Pediatr Oncol; 1983; 11(1):12-9. PubMed ID: 6188032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of chemotherapy followed by pelvic radiation therapy in stage IIIB carcinoma of the cervix.
    Souhami L; Gil RA; Allan SE; Canary PC; Araújo CM; Pinto LH; Silveira TR
    J Clin Oncol; 1991 Jun; 9(6):970-7. PubMed ID: 1709686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment results of adjuvant chemotherapy after radical hysterectomy for intermediate- and high-risk stage IB-IIA cervical cancer.
    Takeshima N; Umayahara K; Fujiwara K; Hirai Y; Takizawa K; Hasumi K
    Gynecol Oncol; 2006 Nov; 103(2):618-22. PubMed ID: 16777200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cis-platinum and mitomycin-C in treatment of recurrent, metastatic, or residual uterine cervical cancer post radiation.
    Senapad S; Neungton S; Usavajindawath C; Vijatrasil S; Thaithanaisawanya V
    J Med Assoc Thai; 1989 Jul; 72(7):382-6. PubMed ID: 2507723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.